“…Improved insights into the relationships between wave aberration and perceived best focus were made possible through accurate measurements of the wave aberrations of the eye using wavefront sensors. 12 Today, ophthalmic wavefront sensor systems are commercially available and appear to optimize image-sharpness metrics using undisclosed algorithms to provide objective measures of the eye's refractive prescription (Visionix, Luneau Technology, France; Pentacam AXL Wave, Oculus, Arlington, WA, USA 13 ; Wavedyn, Wavefront Dynamics, Albuquerque, NM, USA). The use of wavefront sensors to offer objective measures of accommodation is less common (commercial devices: Osiris, CSO Ophthalmic, Scandicci, Italy 14 ; COAS-HD, Wavefront Sciences [no longer commercially available] 15 ; iTrace, Tracey Technologies, Houston, TX, USA 16 ; and several reported research devices 17 – 20 ).…”